U.S. Consumer Durables Stock News

Insiders who bought Bed Bath & Beyond, Inc. ( NYSE:BBBY ) stock in the last 12 months were richly rewarded last week...

ZipRecruiter, Inc. ( NYSE:ZIP ) shares have had a really impressive month, gaining 32% after a shaky period beforehand...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Mobile Infrastructure Corporation's ( NASDAQ:BEEP ) price-to-sales (or "P/S") ratio of 3.1x may not look like an...

The simplest way to invest in stocks is to buy exchange traded funds. But in our experience, buying the right stocks...

There wouldn't be many who think ProPetro Holding Corp.'s ( NYSE:PUMP ) price-to-sales (or "P/S") ratio of 0.8x is...

While Angi Inc. ( NASDAQ:ANGI ) might not have the largest market cap around , it saw a double-digit share price rise...

Key Insights Significantly high institutional ownership implies Forum Energy Technologies' stock price is sensitive to...

Hooker Furnishings Corporation ( NASDAQ:HOFT ) shareholders would be excited to see that the share price has had a...

In Q3 2025, Confluent reported revenue growth of 19% year over year, beating expectations, expanded billings to US$318.1 million, and launched new AI-oriented Intelligence features, Streaming Agents enhancements, and a private cloud offering for regulated industries. At the same time, Jackson Peak Capital highlighted Confluent as its largest, high-conviction, event-driven position with potential acquisition appeal, underscoring how the company’s evolving data streaming platform is...

On December 1, 2025, Northwest Bancshares director John P. Meegan purchased 1,500 shares of the bank’s common stock following the release of third-quarter results, which showed earnings per share below analyst expectations but revenue above forecasts. This combination of insider buying, mixed quarterly performance and flagged liquidity pressures is prompting investors to reassess the bank’s risk-reward profile and operational priorities. Next, we’ll examine how Meegan’s insider purchase,...

If you are wondering whether Akamai Technologies is quietly turning into a value opportunity while many investors focus on flashier tech names, you are not alone. The stock has climbed 22.2% over the last month even though it is still down 7.8% year to date and 9.7% over the past year. This combination often signals shifting market expectations rather than a simple momentum story. Recent attention has centered on Akamai's evolution from a content delivery network provider into a broader...

RingCentral (RNG) just delivered quarterly results and guidance that cleared expectations, and that is what has the stock back on investors radar, even with ongoing insider selling in the background. See our latest analysis for RingCentral. Even with the latest earnings beat giving the story a lift, the 1 year total shareholder return of negative 26.5 percent and 5 year total shareholder return of negative 91.4 percent show that longer term holders are still deep in the red. As a result, the...

Sprinklr (CXM) has just posted another quarter of solid top line and bottom line numbers, with Q2 2026 revenue at about $212 million and basic EPS of roughly $0.05, supported by trailing 12 month revenue of about $821 million and EPS of around $0.47. The company has seen revenue move from roughly $196 million in Q1 2025 to about $212 million in Q2 2026, while basic EPS has ranged from about $0.04 in Q1 2025 to approximately $0.05 in the latest quarter. This sets up a story where profitability...

If you are wondering whether Sempra at around $90 a share is still a solid opportunity or if the easy money has already been made, you are not alone in asking whether the current price really reflects its long term value. Despite a soft patch in the short term, with the stock down 3.3% over the past week and 2.0% over the last month, Sempra is still up 4.1% year to date and has delivered 65.2% over 5 years, which quietly signals durable compounding for patient holders. Recent moves in the...

Chemours (CC) has quietly outperformed the broader materials sector over the past week, even though the stock is still down sharply over the past year, drawing value focused investors back for another look. See our latest analysis for Chemours. With the share price now at $12.96 and a 7 day share price return of 3.93 percent after a tough year to date decline of 22.44 percent, it looks like sentiment is stabilising rather than accelerating, especially given the 1 year total shareholder return...

Huntsman (HUN) has reduced its fourth quarter 2025 adjusted EBITDA outlook after an unplanned disruption at its Rotterdam polyurethanes plant, where the larger MDI production line is expected to remain offline until roughly mid December. See our latest analysis for Huntsman. The update comes after a sharp run, with a 1 month share price return of about 32 percent helping Huntsman claw back some ground despite a much weaker year to date picture and deeply negative multi year total shareholder...

In November 2025, Gentex Corporation and The Genie Company announced an agreement to integrate Genie's Aladdin Connect platform into Gentex's HomeLink system, enabling vehicle-based and app-based control of smart-enabled garage doors via the HomeLink cloud. The partnership extends Gentex's connected-car and smart-home footprint by allowing many existing garage doors to become smart-enabled through Genie's retrofit kits, deepening Gentex's role at the intersection of vehicles and home...

Nelnet (NNI) has quietly rewarded patient investors, with the stock up about 26% year to date and more than doubling over five years, even as annual revenue recently dipped slightly. See our latest analysis for Nelnet. With the share price now at $133.18 and a year to date share price return of about 26 percent, momentum still looks constructive, while the five year total shareholder return of roughly 101 percent underlines how well the story has played out over time. If Nelnet's steady climb...

Recently, Goosehead Insurance President & CEO Mark Miller bought 5,000 additional shares, lifting his ownership to 35,000 shares according to an SEC filing. This insider purchase, combined with fresh but mixed analyst commentary, spotlights growing debate over Goosehead’s broker model, competitive pressures, and growth outlook. Next, we’ll explore how Miller’s increased share ownership could influence Goosehead Insurance’s existing investment narrative and perceived long-term...

Criteo recently reported stronger-than-expected third quarter 2025 results, delivering robust earnings despite challenging market conditions and ongoing shifts in digital advertising. Analysts highlighted Criteo’s exposure to fast-growing areas such as Retail Media and agentic commerce, suggesting its commerce-focused ad infrastructure is gaining relevance with advertisers and partners. We’ll examine how this stronger-than-expected quarterly performance, especially in Retail Media, could...

Recently, analysts reiterated a positive outlook on West Pharmaceutical Services after the company reported strong quarterly results and raised its guidance, citing resilient demand for its high-value proprietary elastomer components and exposure to GLP-1 therapies. This supportive analyst commentary highlights how West’s mix of specialized injectable packaging and long-term GLP-1 demand may help offset concerns about capital allocation, insider selling during buybacks, and potential...

Black Diamond Therapeutics (BDTX) just released topline Phase 2 data for its EGFR inhibitor silevertinib in frontline non small cell lung cancer, while also laying out plans for a randomized Phase 2 trial in newly diagnosed glioblastoma. See our latest analysis for Black Diamond Therapeutics. The latest silevertinib update landed against a choppy backdrop for Black Diamond Therapeutics, with a sharp 1 day share price return of negative 22.03 percent and a 7 day share price return of negative...

Cactus (NYSE:WHD) just amended its ABL credit facility, adding a $100 million delayed draw term loan tied to a potential Baker Hughes Pressure Control acquisition, a material move that reshapes both its balance sheet flexibility and growth narrative. See our latest analysis for Cactus. The amended facility and potential Baker Hughes Pressure Control deal arrive as Cactus posts a seven-day share price return of 8.4 percent but a year-to-date share price return of negative 22.9 percent. The...